Topics
Glioblastoma | Treatment | Targeted therapy | Gallium maltolate
Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Gallium maltolate
Connelly JM, Zoss CJ, Szabo A, Mirza SP, Adom F, Bernstein LR,
Al-Gizawiy MM, Schmainda KM, Chitambar CR.
A
phase 1 trial of iron metabolism-targeting oral gallium maltolate
in recurrent and refractory glioblastoma.
Neurooncol
Adv. 2026 Jun 8;8(1):vdag154. doi:
10.1093/noajnl/vdag154. PMID:
42333305. Trial
registration ID: NCT04319276. ˍ